Skip to main content

Table 2 Demographics and clinical characteristics for participating subjects (n = 328) – earlier clinical trial

From: A novel, accurate, and non-invasive liquid biopsy test to measure cellular immune responses as a tool to diagnose early-stage lung cancer: a clinical trials study

Characteristic

Lung cancer group (n = 82)

Control group (n = 246)

All (n = 328)

Age (years)a

66.7 ± 9.6

65.0 ± 8.1

65.4 ± 8.5

Sex

   

 Male

46

137

183

 Female

36

109

145

Smokers

   

 Current

29

41

70

 Formerb

34

89

123

Clinical stage

   

 I

63

–

–

 II

19

–

–

Histological type

   

 Adenocarcinoma

48

–

–

 Squamous cell carcinoma

19

–

–

 Other non-small cell

8

  

 Small cell

2

  

 Other

5

–

–

  1. aThe age of subjects at blood withdrawal
  2. bSubjects with at least one pack-year in their history, who have not smoked in the past 30 days
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us